Psoriasis vulgaris


psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 L40.0
Hospital discharge: ICD-9 6961A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 L40.0
Cause of death: ICD-9 6961A
Cause of death: ICD-8 $!$
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 L40.0


diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9


diagram downward connector

Check minimum number of events None


diagram downward connector

Include endpoints None


diagram downward connector

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L40
Name in latin Psoriasis vulgaris

Summary Statistics

Key figures

All Female Male
Number of individuals 5219 2453 2766
Unadjusted prevalence (%) 1.47 1.24 1.76
Mean age at first event (years) 50.70 48.66 52.51


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.66 [2.07, 3.41] 1.2e-14 517
15 years 0.01 1.85 [1.47, 2.34] 2.1e-7 265
5 years 0.00 2.72 [2.15, 3.44] 9.4e-17 120
1 year 0.00 3.25 [2.17, 4.88] 1.3e-8 27

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: L12_PSORI_VULG – Psoriasis vulgaris
GWS hits: 19

Survival analyses between endpoints


before Psoriasis vulgaris
after Psoriasis vulgaris

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Psoriasis vulgaris